http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2179422-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80b213cc29d64e9a9c632a5b8825073f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e3ca33fbb336044de363629012f3502 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 |
| filingDate | 1994-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74772610d7f49d9bdc887fa47203c650 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a168309790fa32c506b3bfb19c996d96 |
| publicationDate | 1995-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2179422-A1 |
| titleOfInvention | Means and method for hormonal contraception and/or the treatment of acne |
| abstract | Means for hormonal contraception and/or acne treatment, having two hormone constituents packaged spatially separately in a packaging unit and intended for temporally sequential administration, each of said hormone constituents being composed of a plurality of daily hormone units accommodated spatially separately and individually removable in the packaging unit, whereby a first of said hormone constituents essentially exclusively contains an estrogen preparation effecting a disturbance of the follicle stimulation as active hormonal ingredient, by contrast whereto the second hormone constituent contains an estrogen preparation and a gestagen preparation in a dosing at least adequate for ovulation inhibition in combination, and the total number of daily hormone units is equal to the total number of days of the desired cycle, said first hormone constituent comprises 5-14 and said second hormone constituent comprises 23-14 daily units, and the plurality of daily units of said first hormone constituent is lower than the plurality of daily units of said second hormone constituent, characterized by such an arrangement of the daily units in the packaging unit that the daily units of the second hormone constituent are characterized as those to be taken first and the daily units of the first hormone constituent are characterized as those to be taken following thereupon, whereby the daily units of the second hormone constituent do not contain the combination of a biogenous estrogen and a synthetic estrogen. |
| priorityDate | 1993-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.